Logo image of ALKLK.PA

KERLINK (ALKLK.PA) Stock Fundamental Analysis

EPA:ALKLK - Euronext Paris - Matif - FR0013156007 - Common Stock - Currency: EUR

0.956  +0.02 (+1.92%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALKLK. ALKLK was compared to 26 industry peers in the Communications Equipment industry. ALKLK has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ALKLK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALKLK has reported negative net income.
ALKLK had a positive operating cash flow in the past year.
In the past 5 years ALKLK always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: ALKLK reported negative operating cash flow in multiple years.
ALKLK.PA Yearly Net Income VS EBIT VS OCF VS FCFALKLK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

ALKLK has a worse Return On Assets (-16.25%) than 73.08% of its industry peers.
ALKLK has a Return On Equity of -92.45%. This is in the lower half of the industry: ALKLK underperforms 73.08% of its industry peers.
Industry RankSector Rank
ROA -16.25%
ROE -92.45%
ROIC N/A
ROA(3y)-14.32%
ROA(5y)-15.26%
ROE(3y)-59.86%
ROE(5y)-55.52%
ROIC(3y)N/A
ROIC(5y)N/A
ALKLK.PA Yearly ROA, ROE, ROICALKLK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

Looking at the Gross Margin, with a value of 28.97%, ALKLK is doing worse than 80.77% of the companies in the same industry.
In the last couple of years the Gross Margin of ALKLK has declined.
The Profit Margin and Operating Margin are not available for ALKLK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.77%
GM growth 5Y-8.4%
ALKLK.PA Yearly Profit, Operating, Gross MarginsALKLK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

ALKLK does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALKLK has about the same amout of shares outstanding than it did 1 year ago.
ALKLK has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALKLK has a worse debt to assets ratio.
ALKLK.PA Yearly Shares OutstandingALKLK.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ALKLK.PA Yearly Total Debt VS Total AssetsALKLK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

ALKLK has an Altman-Z score of 0.81. This is a bad value and indicates that ALKLK is not financially healthy and even has some risk of bankruptcy.
ALKLK has a Altman-Z score of 0.81. This is in the lower half of the industry: ALKLK underperforms 61.54% of its industry peers.
ALKLK has a debt to FCF ratio of 5.10. This is a neutral value as ALKLK would need 5.10 years to pay back of all of its debts.
ALKLK's Debt to FCF ratio of 5.10 is in line compared to the rest of the industry. ALKLK outperforms 50.00% of its industry peers.
A Debt/Equity ratio of 2.13 is on the high side and indicates that ALKLK has dependencies on debt financing.
With a Debt to Equity ratio value of 2.13, ALKLK is not doing good in the industry: 73.08% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.13
Debt/FCF 5.1
Altman-Z 0.81
ROIC/WACCN/A
WACC4.59%
ALKLK.PA Yearly LT Debt VS Equity VS FCFALKLK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

ALKLK has a Current Ratio of 1.90. This is a normal value and indicates that ALKLK is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.90, ALKLK perfoms like the industry average, outperforming 57.69% of the companies in the same industry.
ALKLK has a Quick Ratio of 1.90. This is a bad value and indicates that ALKLK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ALKLK (0.88) is worse than 65.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 0.88
ALKLK.PA Yearly Current Assets VS Current LiabilitesALKLK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.69% over the past year.
Looking at the last year, ALKLK shows a very negative growth in Revenue. The Revenue has decreased by -14.86% in the last year.
Measured over the past years, ALKLK shows a decrease in Revenue. The Revenue has been decreasing by -2.20% on average per year.
EPS 1Y (TTM)18.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.41%
Revenue 1Y (TTM)-14.86%
Revenue growth 3Y-16.27%
Revenue growth 5Y-2.2%
Sales Q2Q%-23.41%

3.2 Future

ALKLK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.24% yearly.
Based on estimates for the next years, ALKLK will show a very strong growth in Revenue. The Revenue will grow by 22.13% on average per year.
EPS Next Y37.93%
EPS Next 2Y43.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.28%
Revenue Next 2Y21.36%
Revenue Next 3Y22.13%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALKLK.PA Yearly Revenue VS EstimatesALKLK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
ALKLK.PA Yearly EPS VS EstimatesALKLK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ALKLK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALKLK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALKLK.PA Price Earnings VS Forward Price EarningsALKLK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

ALKLK's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALKLK is cheaper than 92.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.86
EV/EBITDA N/A
ALKLK.PA Per share dataALKLK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as ALKLK's earnings are expected to grow with 43.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.24%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALKLK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KERLINK

EPA:ALKLK (8/6/2025, 7:00:00 PM)

0.956

+0.02 (+1.92%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)07-10 2025-07-10
Earnings (Next)10-14 2025-10-14
Inst Owners13.25%
Inst Owner ChangeN/A
Ins Owners5.6%
Ins Owner ChangeN/A
Market Cap7.14M
Analysts40
Price Target1.12 (17.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.61
P/FCF 2.86
P/OCF 1.99
P/B 1.75
P/tB 7.32
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)0.33
FCFY34.92%
OCF(TTM)0.48
OCFY50.37%
SpS1.56
BVpS0.55
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.25%
ROE -92.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.97%
FCFM 21.38%
ROA(3y)-14.32%
ROA(5y)-15.26%
ROE(3y)-59.86%
ROE(5y)-55.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.77%
GM growth 5Y-8.4%
F-Score5
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 2.13
Debt/FCF 5.1
Debt/EBITDA N/A
Cap/Depr 62.14%
Cap/Sales 9.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.9
Quick Ratio 0.88
Altman-Z 0.81
F-Score5
WACC4.59%
ROIC/WACCN/A
Cap/Depr(3y)95.64%
Cap/Depr(5y)79.23%
Cap/Sales(3y)11.29%
Cap/Sales(5y)9.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.41%
EPS Next Y37.93%
EPS Next 2Y43.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.86%
Revenue growth 3Y-16.27%
Revenue growth 5Y-2.2%
Sales Q2Q%-23.41%
Revenue Next Year16.28%
Revenue Next 2Y21.36%
Revenue Next 3Y22.13%
Revenue Next 5YN/A
EBIT growth 1Y1.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3Y42.88%
EBIT Next 5YN/A
FCF growth 1Y774.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y190.32%
OCF growth 3YN/A
OCF growth 5YN/A